Genotypic and phenotypic characteristics of DENV-3 isolated from patients with different disease severities in Indonesia

Dengue Bulletin

Volumn 33, Issue 1, 2009, Pages 45-59

  Dewi, Beti Ernawati ^a,b   Takasaki, Tomohiko ^a   Tajima, Shigeru ^a   Sudiro, T Mirawati ^b   Larasati, R P ^c   Corwin, Andrew Lee ^c   Kurane, Ichiro ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b UNIVERSITY OF INDONESIA   (Indonesia)

^c US Naval Medical Research Unit No 2 Jakarta   (Indonesia)

Author keywords

DENV 3; Genotypic characteristics; Indonesia; Phenotypic characteristics

Indexed keywords

AMINO ACID; M PROTEIN; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 2; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; NONSTRUCTURAL PROTEIN 4B; NONSTRUCTURAL PROTEIN 5; NUCLEOTIDE; STRUCTURAL PROTEIN;

3' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS 3; DISEASE SEVERITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; INDONESIA; MONOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PHYLOGENY; VIROGENESIS; VIRUS ISOLATION;

EID: 81855176394     PISSN: 1020895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Bosch I, Xhaja K, Estevez L, Raines G, Melichar H, Warke RV, Fournier MV, Ennis FA, Rothman AL. Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J Virol 2002;76:5588-5597. (Pubitemid 34517909)
2. Bray M, Men R, Tokimatsu I, Lai CJ. Genetic determinants responsible for acquisition of dengue type 2 virus mouse neurovirulence. J Virol 1998;72(2):1647-1651. (Pubitemid 28116956)
3. Chambers TJ, Hahn CS, Galler R, Rice CM. Flavivirus genome organization, expression, and replication. Annu Rev Microbiol 1990;44:649-688.
4. Chen CJ, Kuo MD, Chien LJ, Hsu SL, Wang YM, Lin JH. RNA-protein interactions: involvement of NS3, NS5, and 3′ noncoding regions of Japanese encephalitis virus genomic RNA. J Virol 1997;71(5): 3466-3473.
5. Cologna R, Rico-Hesse R. American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J Virol 2003;77(7):3929-3938. (Pubitemid 36350934)
6. Corwin AL, Larasati RP, Bangs MJ, Wuryadi S, Arjoso N, Sukri, Listyaningsih E, Hartati S. Namursa R, Anwar Z, Chandra S, Loho B, Ahmad H, Campbell JR, Porter KR. Epidemic dengue transmission in southern Sumatra, Indonesia. Trans R Soc Trop Med Hyg 2001;95:257-265.
7. Crill WD, Roehrig JT. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol 2001;75(16):7769-7773. (Pubitemid 32738039)
8. Diamond MS, Edgil D, Roberts TG, Lu B, Harris E. Infection of human cells by dengue virus is modulated by different cell types and viral strains. J. Virol 2000;74:7814-7823. (Pubitemid 30641625)
9. Duarte dos Santos CN, Frenkiel MP, Courageot MP, Rocha CF, Vazeille-Falcoz MC, Wien MW, Rey FA, Deubel V, Despres P. Determinants in the envelope E protein and viral RNA helicase NS3 that influence the induction of apoptosis in response to infection with dengue type 1 virus. Virology 2000;274(2):292-308.
10. Falconar AK. Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins. Arch Virol 1999;144(12):2313-2330. (Pubitemid 30057171)
11. Gualano RC, Pryor MJ, Cauchi MR, Wright PJ, Davidson AD. Identification of a major determinant of mouse neurovirulence of dengue virus type 2 using stably cloned genomic-length cDNA. J Gen Virol 1998; 9(Pt 3):437-446. (Pubitemid 28115866)
12. Gubler DJ, Suharyono W, Lubis I, Eram S, Sulianti Saroso J. Epidemic dengue hemorrhagic fever in rural Indonesia. I. Virological and epidemiological studies. Am J Trop Med Hyg 1979;28(4):701-710. (Pubitemid 9233206)
13. Guirakhoo F, Hunt AR, Lewis JG, Roehrig JT. Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH. Virology 1993;194(1):219-223.
14. Halstead SB. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis 1979;140:527-533. (Pubitemid 10172725)
15. Halstead SB, O'Rourke EJ. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 1977;265(5596):739-741. (Pubitemid 8039460)
16. Ho LJ, Wang JJ, Shaio MF, Kao CL, Chang DM, Han SW, Lai JH. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol 2001;166(3):1499-1506.
17. Innis BL, Nisalak A, Nimmannitya S, Kusalerdchariya S, Chongswasdi V, Suntayakorn S, Puttisri P, Hoke CH. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg 1989;40(4):418-427. (Pubitemid 19117542)
18. Ito M, Takasaki T, Yamada K, Nerome R, Tajima S, Kurane I. Development and evaluation of fluorogenic TaqMan reverse transcriptase PCR assays for detection of dengue virus types 1 to 4. J Clin Microbiol 2004;42(12):5935-5937. (Pubitemid 39664400)
19. Khromykh AA, Sedlak PL, Guyatt KJ, Hall RA, Westaway EG. Efficient trans-complementation of the flavivirus kunjin NS5 protein but not of the NS1 protein requires its coexpression with other components of the viral replicase. J Virol 1999;73(12):10272-10280.
20. Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 1989;40(4):444-451. (Pubitemid 19117544)
21. Lanciotti RS, Lewis JG, Gubler DJ, Trent DW. Molecular evolution and epidemiology of dengue-3 viruses. J Gen Virol 1994;75(Pt 1):65-75. (Pubitemid 24033981)
22. Lee E, Gubler DJ, Weir RC, Dalgarno L. Genetic and biological differentiation of dengue 3 isolates obtained from clinical cases in Java, Indonesia, 1976-1978. Archives of Virology 1993:133;112-125.
23. Leitmeyer KC, Vaughn DW, Watts DM, Salas R, Villalobos I, de Chacon, Ramos C, Rico-Hesse R. Dengue virus structural differences that correlate with pathogenesis. J Virol 1999;73:4738-4747. (Pubitemid 29246733)
24. Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S, Vaughn DW, Nisalak A, Ennis FA, Rothman AL. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis 2002;186(8):1165-1168. (Pubitemid 35177121)
25. Lindenbach BD, Rice CM. Genetic interaction of flavivirus nonstructural proteins NS1 and NS4A as a determinant of replicase function. J Virol 1999;73(6):4611-4621. (Pubitemid 29246719)
26. Lok SM, Ng ML, Aaskov J. Amino acid and phenotypic changes in dengue 2 virus associated with escape from neutralisation by IgM antibody. J Med Virol 2001;65(2):315-323.
27. Mangada MN, Igarashi A. Molecular and in vitro analysis of eight dengue type 2 viruses isolated from patients exhibiting different disease severities. Virology 1998;244(2):458-466. (Pubitemid 28384107)
28. Morens DM, Marchette NJ, Chu MC, Halstead SB. Growth of dengue type 2 virus isolates in human peripheral blood leukocytes correlates with severe and mild dengue disease. Am J Trop Med Hyg 1991;45(5):644-651.
29. Murgue B, Roche C, Chungue E, Deparis X. Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia. J Med Virol 2000;60(4):432-438. (Pubitemid 30127315)
30. Pandey BD, Igarashi A. Severity-related molecular differences among nineteen strains of dengue type 2 viruses. Microbiol Immunol 2000;44(3):179-188. (Pubitemid 30190915)
31. R Putnak, Feighny R, Burrous R, Cochran M, Hackett M, Smith G, Hoke C. Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virusneutralizing antibody in mice and protects them from virus challenge. Am J Trop Med Hyg 1991;45:159-167.
32. Pryor MJ, Carr JM, Hocking H, Davidson AD, Li P, Wright PJ. Replication of dengue virus type 2 in human monocyte-derived macrophages: comparisons of isolates and recombinant viruses with substitutions at amino acid 390 in the envelope glycoprotein. Am J Trop Med Hyg 2001:65(5):427-434. (Pubitemid 33134573)
33. Rice CM, Lenches EM, Eddy SR, Shin SJ, Sheets RL, Strauss JH. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 1985;229(4715):726-733. (Pubitemid 15006393)
34. Rico-Hesse R, Harrison LM, Salas RA, Tovar D, Nisalak A, Ramos C, Boshell J, de Mesa MT, Nogueira RM, da Rosa AT. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 1997;230:244-251. (Pubitemid 27211855)
35. Roehrig JT, Bolin RA, Kelly RG. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology 1998;246(2):317-328. (Pubitemid 28384045)
36. Roehrig JT, Risi PA, Brubaker JR, Hunt AR, Beaty BJ, Trent DW, Mathews JH. T-helper cell epitopes on the E-glycoprotein of dengue 2 Jamaica virus. Virology 1994;198(1):31-38.
37. Sanchez IJ, Ruiz BH. A single nucleotide change in the E protein gene of dengue virus 2 Mexican strain affects neurovirulence in mice. J Gen Virol 1996;77:2541-2545. (Pubitemid 26348377)
38. Scott RM, Nisalak A, Cheamudon U, Seridhoranakul S, Nimmannitya S. Isolation of dengue viruses from peripheral blood leukocytes of patients with hemorrhagic fever. J Infect Dis 1980;141:1-6. (Pubitemid 10133827)
39. Uzcategui NY, Comach G, Camacho D, Salcedo M, Cabello de Quintana M, Jimenez M, Sierra G, Cuello de Uzcategui R, James WS, Turner S, Holmes EC, Gould EA. Molecular epidemiology of dengue virus type 3 in Venezuela. J Gen Virol 2003;84(Pt 6):1569-1575. (Pubitemid 36675528)
40. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Endy TP, Raengsakulrach B, Rothman AL, Ennis FA, Nisalak A. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000;181(1):2-9. (Pubitemid 30049026)
41. Watts DM, Porter KR, Putvatana P, Vasquez B, Calampa C, Hayes CG, Halstead SB. Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. Lancet 1999;354(9188):1431-1434. (Pubitemid 29494755)
42. Wills BA, Oragui EE, Stephens AC, Daramola OA, Dung NM, Loan HT, Chau NV, Chambers M, Stepniewska K, Farrar JJ, Levin M. Coagulation abnormalities in dengue hemorrhagic Fever: serial investigations in 167 Vietnamese children with dengue shock syndrome. Clin Infect Dis 2002;35(3):277-285. (Pubitemid 34800275)
43. Wittke V, Robb TE, Thu HM, Nisalak A, Nimmannitya S, Kalayanrooj S, Vaughn DW, Endy TP, Holmes EC, Aaskov JG. Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period. Virology 2002;301(1):148-156. (Pubitemid 35168510)
44. World Health Organization. Dengue and Dengue hemorrhagic fever. Fact sheet no. 117. Geneva: WHO, 2002.
45. Wu HC, Huang YL, Chao TT, Jan JT, Huang JL, Chiang HY, King CC, Shaio MF. Identification of B-cell epitope of dengue virus type 1 and its application in diagnosis of patients. J Clin Microbiol 2001;39(3):977-982.
46. Yamada K, Takasaki T, Nawa M, Kurane I. Virus isolation as one of the diagnostic methods for dengue virus infection. J Clin Virol 2002;24, 203-209. (Pubitemid 34150172)